Works by LEE, GARAM


Results: 35
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Alzheimer's disease drug development pipeline: 2025.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025, v. 11, n. 2, p. 1, doi. 10.1002/trc2.70098
    By:
    • Cummings, Jeffrey L.;
    • Zhou, Yadi;
    • Lee, Garam;
    • Zhong, Kate;
    • Fonseca, Jorge;
    • Leisgang‐Osse, Amanda M.;
    • Cheng, Feixiong
    Publication type:
    Article
    20

    Alzheimer's disease drug development pipeline: 2024.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2024, v. 10, n. 2, p. 1, doi. 10.1002/trc2.12465
    By:
    • Cummings, Jeffrey;
    • Zhou, Yadi;
    • Lee, Garam;
    • Zhong, Kate;
    • Fonseca, Jorge;
    • Cheng, Feixiong
    Publication type:
    Article
    21

    Alzheimer's disease drug development pipeline: 2023.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2023, v. 9, n. 2, p. 1, doi. 10.1002/trc2.12385
    By:
    • Cummings, Jeffrey;
    • Zhou, Yadi;
    • Lee, Garam;
    • Zhong, Kate;
    • Fonseca, Jorge;
    • Cheng, Feixiong
    Publication type:
    Article
    22

    Alzheimer's disease drug development pipeline: 2022.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12295
    By:
    • Cummings, Jeffrey;
    • Lee, Garam;
    • Nahed, Pouyan;
    • Nojoo Kambar, Mina Esmail Zadeh;
    • Zhong, Kate;
    • Fonseca, Jorge;
    • Taghva, Kazem
    Publication type:
    Article
    23

    Who funds Alzheimer’s disease drug development?

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12185
    By:
    • Cummings, Jeffrey;
    • Bauzon, Justin;
    • Lee, Garam
    Publication type:
    Article
    24

    Alzheimer’s disease drug development pipeline: 2021.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2021, v. 7, n. 1, p. 1, doi. 10.1002/trc2.12179
    By:
    • Cummings, Jeffrey;
    • Lee, Garam;
    • Zhong, Kate;
    • Fonseca, Jorge;
    • Taghva, Kazem
    Publication type:
    Article
    25

    Alzheimer's disease drug development pipeline: 2020.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2020, v. 6, n. 1, p. 1, doi. 10.1002/trc2.12050
    By:
    • Cummings, Jeffrey;
    • Lee, Garam;
    • Ritter, Aaron;
    • Sabbagh, Marwan;
    • Zhong, Kate
    Publication type:
    Article
    26

    Alzheimer's disease drug development pipeline: 2019.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2019, v. 5, n. 1, p. 272, doi. 10.1016/j.trci.2019.05.008
    By:
    • Cummings, Jeffrey;
    • Lee, Garam;
    • Ritter, Aaron;
    • Sabbagh, Marwan;
    • Zhong, Kate
    Publication type:
    Article
    27

    Alzheimer's disease drug development pipeline: 2018.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2018, v. 4, n. 1, p. 195, doi. 10.1016/j.trci.2018.03.009
    By:
    • Cummings, Jeffrey;
    • Lee, Garam;
    • Ritter, Aaron;
    • Zhong, Kate
    Publication type:
    Article
    28
    29
    30
    31
    32

    P4‐016: MCLENA‐1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1279, doi. 10.1016/j.jalz.2019.06.3675
    By:
    • Decourt, Boris;
    • Fulkerson, Nadia;
    • Burns, Alana;
    • Lee, Garam;
    • St Rose, Tessa;
    • Hartley, Katurah;
    • Dardis, Christopher;
    • Wilson, Jeffrey;
    • Sabbagh, Marwan N.
    Publication type:
    Article
    33
    34
    35